{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T22:55:09Z","timestamp":1793141709230,"version":"4.5.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.ejmech.2017.05.054","type":"journal-article","created":{"date-parts":[[2017,5,30]],"date-time":"2017-05-30T11:34:16Z","timestamp":1496144056000},"page":"196-210","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["New quinoline-arylamidine hybrids: Synthesis, DNA\/RNA binding and antitumor activity"],"prefix":"10.1016","volume":"137","author":[{"given":"Luka","family":"Krstulovi\u0107","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivana","family":"Stoli\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marijana","family":"Juki\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teuta","family":"Opa\u010dak-Bernardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Star\u010devi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miroslav","family":"Baji\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ljubica","family":"Glava\u0161-Obrovac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2017.05.054_bib1","doi-asserted-by":"crossref","first-page":"3145","DOI":"10.1007\/s00018-008-8111-5","article-title":"An overview of cancer multidrug resistance: a still unsolved problem","volume":"65","author":"Lage","year":"2008","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.ejmech.2017.05.054_bib2","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.drup.2009.07.001","article-title":"Understanding the causes of multidrug resistance in cancer: a comparison of doxorubicin and sunitinib","volume":"12","author":"Broxterman","year":"2009","journal-title":"Drug Resist. Update"},{"key":"10.1016\/j.ejmech.2017.05.054_bib3","doi-asserted-by":"crossref","first-page":"7874","DOI":"10.1021\/jm5006463","article-title":"Polypharmacology: challenges and opportunities in drug discovery","volume":"57","author":"Anighoro","year":"2014","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2017.05.054_bib4","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1517\/17460441.2013.798296","article-title":"Advances in the development of hybrid anticancer drugs","volume":"8","author":"Fortin","year":"2013","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.ejmech.2017.05.054_bib5a","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1021\/ar7000843","article-title":"Hybrid molecules with a dual mode of action: dream or reality?","volume":"41","author":"Meunier","year":"2008","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.ejmech.2017.05.054_bib5b","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/ddr.20345","article-title":"Next-generation antimalarial drugs: hybrid molecules as a new strategy in drug design","volume":"71","author":"Muregi","year":"2010","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.ejmech.2017.05.054_bib6","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.ejmech.2014.03.018","article-title":"Rational approaches, design strategies, structure activity relationship and mechanistic insights for anticancer hybrids","volume":"77","author":"Nepali","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.05.054_bib7","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1517\/13543776.2015.1050791","article-title":"Chloroquine-containing compounds: a patent review (2010-2014)","volume":"25","author":"Njaria","year":"2015","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.ejmech.2017.05.054_bib8","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1158\/0008-5472.CAN-12-2464","article-title":"Chloroquine in cancer therapy: a double-edged sword of autophagy","volume":"73","author":"Kimura","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2017.05.054_bib9","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.ejphar.2009.06.063","article-title":"Chloroquine and its analogs: a new promise of an old drug for effective and safe cancer therapies","volume":"625","author":"Solomon","year":"2009","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2017.05.054_bib10","doi-asserted-by":"crossref","first-page":"3218","DOI":"10.1016\/j.bmc.2005.12.035","article-title":"Chloroquine inhibits growth and induces cell death in A549 lung cancer cells","volume":"14","author":"Fan","year":"2006","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.05.054_bib11","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1111\/bph.13045","article-title":"Synergistic anti-tumour effects of tetrandrine and chloroquine combination therapy in human cancer: a potential antagonistic role for p21","volume":"172","author":"Mei","year":"2015","journal-title":"Brit. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2017.05.054_bib12a","doi-asserted-by":"crossref","first-page":"3474","DOI":"10.1039\/C5NJ00094G","article-title":"4-Aminoquinoline-pyrimidine-aminoalkanols: synthesis, in\u00a0vitro antimalarial activity, docking studies and ADME predictions","volume":"39","author":"Tripathi","year":"2015","journal-title":"New J. Chem."},{"key":"10.1016\/j.ejmech.2017.05.054_bib12b","first-page":"20729","article-title":"Synthesis of piperazine tethered 4-aminoquinoline-pyrimidine hybrids as potent antimalarial agents","volume":"4","author":"Thakur","year":"2014","journal-title":"RCS Adv."},{"key":"10.1016\/j.ejmech.2017.05.054_bib12c","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1021\/jm4014778","article-title":"Quinoline-pyrimidine hybrids: synthesis, antiplasmodial activity, SAR, and mode of action studies","volume":"57","author":"Singh","year":"2014","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2017.05.054_bib13","first-page":"7062","article-title":"Anticancer activity of 4-aminoquinoline-triazine based molecular hybrids","volume":"4","author":"Manohar","year":"2014","journal-title":"RCS Adv."},{"key":"10.1016\/j.ejmech.2017.05.054_bib14","doi-asserted-by":"crossref","first-page":"18656","DOI":"10.3390\/molecules191118656","article-title":"Synthesis and in\u00a0vitro antitumor activity of a novel series of 2-pyrazoline derivatives bearing the 4-Aryloxy-7-chloroquinoline fragment","volume":"19","author":"Montoya","year":"2014","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2017.05.054_bib15","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.mrfmmm.2005.03.022","article-title":"The influence of N-dialkyl and other cationic substituents on DNA intercalation and genotoxicity","volume":"578","author":"Snyder","year":"2005","journal-title":"Mutat. Res."},{"key":"10.1016\/j.ejmech.2017.05.054_bib16","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/0005-2787(66)90078-5","article-title":"Evidence for intercalation of chloroquine into DNA","volume":"129","author":"O'Brien","year":"1966","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejmech.2017.05.054_bib17","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ejphar.2010.09.005","article-title":"Design and screening of ASIC inhibitors based on aromatic diamidines for combating neurological disorders","volume":"648","author":"Chen","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2017.05.054_bib18","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1021\/jm901852f","article-title":"Synthesis and biological Evaluation of botulinum neurotoxin A protease inhibitors","volume":"53","author":"Li","year":"2010","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2017.05.054_bib19","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.ejmech.2013.02.026","article-title":"New anticancer active and selective phenylene-bisbenzothiazoles: synthesis, antiproliferative evaluation and DNA binding","volume":"63","author":"Racane","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.05.054_bib20","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1017\/S0031182013000292","article-title":"Novel amidines and analogues as promising agents against intracellular parasites: a systematic review","volume":"140","author":"Soeiro","year":"2013","journal-title":"Parasitology"},{"key":"10.1016\/j.ejmech.2017.05.054_bib21","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1021\/jm501449u","article-title":"Antibacterial drug leads: DNA and enzyme multitargeting","volume":"58","author":"Zhu","year":"2015","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2017.05.054_bib22","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ejmech.2014.11.003","article-title":"Synthesis and structure-activity relationship of amidine derivatives of 3,4-ethylenedioxythiophene as novel antibacterial agents","volume":"90","author":"Stoli\u0107","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.05.054_bib23","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1039\/a705982e","article-title":"DNA minor-groove recognation by small molecule","volume":"18","author":"Neidle","year":"2001","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.ejmech.2017.05.054_bib24","doi-asserted-by":"crossref","first-page":"389","DOI":"10.2174\/1568011054222319","article-title":"Dications that target the DNA minor groove: compound design and preparation, DNA interactions, cellular distribution and biological activity","volume":"5","author":"Wilson","year":"2005","journal-title":"Curr. Med. Chem.-Anti-Cancer Agents"},{"key":"10.1016\/j.ejmech.2017.05.054_bib25","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ejmech.2016.01.022","article-title":"Non-symmetrical furan-amidines as novel leads for the treatment of cancer and malaria","volume":"111","author":"Alnabulsi","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.05.054_bib26","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1016\/j.bmcl.2016.03.082","article-title":"Synthesis and pharmacological evaluation of mono-arylimidamides as antileishmanial agents","volume":"26","author":"Zhu","year":"2016","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2017.05.054_bib27","doi-asserted-by":"crossref","first-page":"5811","DOI":"10.1016\/j.bmcl.2009.01.111","article-title":"Pharmacophore-guided lead optimization: the rational design of a non-zinc coordinating, sub-micromolar inhibitor of the botulinum neutrotoxin serotype a metalloprotease","volume":"19","author":"Burnett","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2017.05.054_bib28","doi-asserted-by":"crossref","first-page":"3411","DOI":"10.1021\/jm501809x","article-title":"Antimalarial activity of 4-amidinoquinoline and 10-amidinobenzonaphthyridine derivatives","volume":"58","author":"Korotchenko","year":"2015","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2017.05.054_bib29","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1016\/j.bmc.2009.01.071","article-title":"Lj. Glava\u0161-Obrovac, Effect of 3,4-ethylenedioxy-extension of thiophene core on the DNA\/RNA binding properties and biological activity of bisbenzimidazole amidines","volume":"17","author":"Stoli\u0107","year":"2009","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.05.054_bib30","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.ejmech.2010.12.010","article-title":"Synthesis, DNA\/RNA affinity and antitumour activity of new aromatic diamidines linked by 3,4-ethylenedioxythiophene","volume":"46","author":"Stoli\u0107","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2017.05.054_bib31","doi-asserted-by":"crossref","first-page":"457","DOI":"10.5562\/cca2141","article-title":"Synthesis, DNA interactions and anticancer evaluation of novel diamidine derivatives of 3,4-ethylenedioxythiophene","volume":"85","author":"Stoli\u0107","year":"2012","journal-title":"Croat. Chem. Acta"},{"key":"10.1016\/j.ejmech.2017.05.054_bib32","doi-asserted-by":"crossref","first-page":"5867","DOI":"10.1128\/AAC.01595-15","article-title":"An aromatic diamidine that targets kinetoplast DNA, impairs the cell cycle in Trypanosoma cruzi, and diminishes trypomastigote release from infected mammalian host cells","volume":"60","author":"Girard","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2017.05.054_bib33","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1002\/jhet.5570330463","article-title":"Synthesis of mono-cationic and dicationic analogs of Hoechst 33258","volume":"33","author":"Czarny","year":"1996","journal-title":"J.\u00a0Heterocycl. Chem."},{"key":"10.1016\/j.ejmech.2017.05.054_bib34","doi-asserted-by":"crossref","first-page":"3637","DOI":"10.1021\/jm200149e","article-title":"Enone- and chalcone-chloroquinoline hybrid analogues: in silico guided design, synthesis, antiplasmodial activity, in\u00a0vitro metabolism, and mechanistic studies","volume":"54","author":"Guantai","year":"2011","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2017.05.054_bib35","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1021\/ja01211a032","article-title":"Synthesis of certain simple 4-aminoquinoline derivatives","volume":"68","author":"Elderfield","year":"1946","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2017.05.054_bib36","series-title":"Hybrid Molecules QA where Q Is an Aminoquinoline and a Is an Antibiotic Residue, the Synthesis and Uses Thereof as Antibacterial Agents","author":"Sanchez","year":"2007"},{"key":"10.1016\/j.ejmech.2017.05.054_bib37","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/0022-2836(74)90031-X","article-title":"Theoretical aspects of DNA-protein interactions: Co-operative and non co-operative binding of large ligands to a one-dimensional homogeneous lattice","volume":"86","author":"McGhee","year":"1974","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.ejmech.2017.05.054_bib38","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.3762\/bjoc.10.225","article-title":"Molecular recognition of AT-DNA sequences by the induced CD pattern of dibenzotetraaza[14]annulene (DBTAA)\u2013adenine derivatives","volume":"10","author":"Radi\u0107 Stojkovi\u0107","year":"2014","journal-title":"Beilstein J. Org. Chem."},{"key":"10.1016\/j.ejmech.2017.05.054_bib39","series-title":"Biophysical Chemistry","first-page":"1109","author":"Cantor","year":"1980"},{"key":"10.1016\/j.ejmech.2017.05.054_bib40","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1562\/2005-01-25-IR-427","article-title":"Intercalation of organic dye molecules into double-stranded DNA. Part 2: the annelated quinolizinium ion as a structural motif in DNA intercalators","volume":"81","author":"Ihmels","year":"2005","journal-title":"Photochem. Photobiol."},{"key":"10.1016\/j.ejmech.2017.05.054_bib41","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.molstruc.2016.11.074","article-title":"Lj. Glava\u0161-Obrovac, Antitumor activity of 3,4-ethylenedioxythiophene derivatives and quantitative structure-activity relationship analysis","volume":"1133","author":"Juki\u0107","year":"2017","journal-title":"J.\u00a0Mol. Struct."},{"key":"10.1016\/j.ejmech.2017.05.054_bib42","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13065-016-0164-1","article-title":"Novel chloroquinoline derivatives incorporating biologically active benzenesulfonamide moiety: synthesis, cytotoxic activity and molecular docking","volume":"10","author":"Ghorab","year":"2016","journal-title":"Chem. Cent. J."},{"key":"10.1016\/j.ejmech.2017.05.054_bib43","first-page":"130","article-title":"Use of quinoline derivatives in cancer","volume":"4","author":"Sharma","year":"2015","journal-title":"IJPRBS"},{"key":"10.1016\/j.ejmech.2017.05.054_bib44","first-page":"212","article-title":"Chemistry and biology of DNA-binding small molecules","volume":"102","author":"Paul","year":"2012","journal-title":"Curr. Sci."},{"key":"10.1016\/j.ejmech.2017.05.054_bib45","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1126\/science.274.5293.1672","article-title":"Cancer cell cycles","volume":"274","author":"Sherr","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2017.05.054_bib46","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1038\/onc.2011.451","article-title":"Checkpoint control and cancer","volume":"31","author":"Medema","year":"2012","journal-title":"Oncogene"},{"key":"10.1016\/j.ejmech.2017.05.054_bib47","doi-asserted-by":"crossref","first-page":"00009","DOI":"10.3389\/fphar.2012.00009","article-title":"Defective cell cycle checkpoints as targets for anti-cancer therapies","volume":"3","author":"Gabrielli","year":"2012","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2017.05.054_bib48","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/B978-0-12-385493-3.00004-8","article-title":"Chapter 4-apoptosis and beyond: cytometry in studies of programmed cell death","volume":"103","author":"Wlodkowic","year":"2011","journal-title":"Methods Cell Biol."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523417304233?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523417304233?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T12:16:41Z","timestamp":1719231401000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523417304233"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":51,"alternative-id":["S0223523417304233"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2017.05.054","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New quinoline-arylamidine hybrids: Synthesis, DNA\/RNA binding and antitumor activity","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2017.05.054","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}